Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$216,440
+$95,863 QoQ
Shares Held
74,893
0.0% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Derivatives in MGNX
reported options exposure · as of Mar 31, 2024CallValue
$7,705,920
CallShares
523,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ikarian Capital, LLC holds $659,799,686 across 106 Biotechnology names. MGNX ranks #93 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
1,456,378 | $76,780,248 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,265,795 | $48,252,105 | |
| 3 | ALMS |
Alumis Inc.
|
1,213,548 | $26,734,462 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
428,682 | $24,910,711 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
71,581 | $23,062,682 | |
| 6 | RLMD |
Relmada Therapeutics, Inc.
|
2,688,359 | $18,710,978 | |
| 7 | CYTK |
Cytokinetics Inc
|
283,572 | $18,690,230 | |
| 8 | TENX |
Tenax Therapeutics, Inc.
|
1,017,600 | $16,271,424 |
All Filings in MGNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $216,440 | 74,893 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $120,577 | 74,893 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $134,519 | 80,071 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $96,885 | 80,071 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $101,690 | 80,071 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $260,230 | 80,071 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $263,459 | 80,079 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $850,335 | 200,079 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,705,920 | 523,500 | Call | Sole | 2024-05-17 | |
| 2024-03-31 | $4,683,418 | 318,167 | Shares | Sole | 2024-05-17 | |
| 2023-03-31 | $1,792,500 | 250,000 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $1,445,888 | 164,119 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,504,554 | 156,047 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,946,729 | 188,478 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $9,339,240 | 446,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $12,344,909 | 459,602 | Shares | Sole | 2021-08-18 | |
| 2021-06-30 | $8,058,000 | 300,000 | Call | Sole | 2021-08-18 | |
| 2021-03-31 | $6,370,000 | 200,000 | Call | Sole | 2021-08-18 | |
| 2021-03-31 | $15,939,937 | 500,469 | Shares | Sole | 2021-08-18 | |
| 2020-03-31 | $2,095,374 | 360,030 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||